Michael A. Pereira is a seasoned regulatory and quality executive with over three decades of experience guiding companies through the complex intersection of FDA compliance, global regulatory standards, and business operations. Known for his ability to build and remediate Quality Management Systems across diverse healthcare sectors—including drug, device, biologic, and combination products—Michael has led strategic initiatives for startups and global enterprises alike. With a rare ability to bridge technical and business teams, he brings clarity, structure, and strategic foresight to every challenge, earning a reputation as a trusted leader and advisor in highly regulated industries.

Brian Dakin, PMP, CIPM, is a seasoned leader in project management, data privacy, and technology solutions within the life sciences industry. As the Principal of Rhombus Consulting, he has driven strategic initiatives that enhance operational efficiency, regulatory compliance, and data governance for pharmaceutical and biotechnology organizations. In his role as President and Head of Operations for a trusted third-party entity, he has led efforts in patient de-identification, achieving HIPAA and SOC2 Type 2 compliance while increasing revenue and profitability. A thought leader and member of the Forbes Coaches Council, Brian also developed **On The Ball Theory**, a framework designed to help individuals unlock their potential and achieve meaningful personal and professional goals. His extensive experience, combined with his commitment to innovation and mentorship, has positioned him as an influential figure in both corporate leadership and personal development.

As a physician-scientist and biotech executive, I have dedicated my career to bridging the gap between groundbreaking medical research and commercial success. From securing multimillion-dollar funding to leading strategic M&A deals, my passion lies in driving healthcare innovation that delivers real-world impact. Here is my biography.

Melany Elicker is a seasoned enterprise leader with over 30 years of experience in supply chain management, ERP implementations, and global business transformation. Specializing in JD Edwards EnterpriseOne, she has successfully led large-scale system rollouts and integrations for industry leaders such as Stryker, Baxter Pharmaceuticals, and Ingersoll Rand. With a strong strategic mindset and deep technical expertise, Melany excels in aligning business objectives with technology solutions to drive operational efficiency, compliance, and scalability. She is a trusted advisor known for her analytical approach, cross-functional leadership, and ability to manage complex onshore and offshore project implementations. Passionate about mentorship and continuous learning, Melany actively contributes her expertise through board advisory roles, helping organizations innovate and grow in an evolving digital landscape.

Excited to share my executive biography, highlighting my journey in digital transformation, AI, and manufacturing innovation. With over 23 years of experience, I am passionate about leveraging technology to drive business success and mentoring teams to achieve excellence.

I am excited to share my executive biography, which highlights my journey in medical affairs, pharma sales, and scientific exchange. With over 22 years of experience leading high-performing teams, optimizing strategic execution, and driving AI-enabled learning, I am passionate about advancing patient outcomes and fostering innovation in healthcare. I am currently seeking board opportunities to expand my influence and contribute my expertise beyond my current space.

Steve Gordon is a seasoned executive, entrepreneur, and innovator with over 40 years of leadership experience across manufacturing, consumer products, scientific instruments, and food & beverage industries. A proven expert in product development, venture capital, mergers & acquisitions, and automation, he has successfully founded, scaled, and exited multiple companies, including leading Intelligent Bio-Systems to a successful acquisition by Qiagen. Currently serving as CEO of Swish Hoop, Steve continues to drive innovation with patented sports technology solutions. With over 50 patents, extensive board experience, and a passion for mentoring and strategic growth, he is actively seeking advisory and board roles where he can apply his expertise to help organizations navigate innovation, commercialization, and market expansion.

Excited to share my professional executive biography! With over 20 years of experience in biotech program management, drug development, and regulatory strategy, I have had the privilege of leading cross-functional teams, guiding early-stage startups, and ensuring successful clinical execution. If you're looking for strategic leadership, operational excellence, and industry expertise, I’d love to connect and explore opportunities to collaborate.

Zach Papin is a results-driven technology and data strategy leader with a proven track record of delivering transformative outcomes across diverse industries. With deep expertise in AI, cloud architecture, and data analytics, he has successfully led high-impact initiatives, including the development of secure generative AI products and acting as interim CIO for a billion-dollar ESG startup. Zach’s ability to align cutting-edge technology with strategic business goals has been instrumental in driving efficiency, reducing technical debt, and fostering innovation. A thought leader and trusted advisor, he has authored influential white papers and guided private equity and venture capital firms through over 100 technology due diligences. Through his strong leadership, strategic vision, and exceptional communication skills, Zach continues to empower organizations to unlock their full potential in a rapidly evolving digital landscape.

Peter Payne is a highly accomplished executive with over 30 years of leadership experience in the pharmaceutical, biotechnology, and contract research organization (CRO) industries. Known for his integrity and results-driven approach, Peter has successfully led organizations through periods of significant growth and transformation. With deep expertise in drug development, clinical trials, and corporate strategy, he has built a strong reputation for driving innovation and strategic partnerships. His leadership spans notable roles, including Vice President at Optum, President of Gennaker Bio, and CEO at multiple biotech companies. Peter’s ability to communicate complex strategies and foster cross-functional collaboration has made him a respected figure in the life sciences industry.

Michael Ekstut is a seasoned business leader with over 30 years of experience in the life sciences industry, specializing in drug discovery, development, and regulatory strategy. He has held senior leadership roles at industry-leading companies, including Certara, where he guided the company’s commercial and product strategy in the regulatory and access sector. Michael is known for his strategic vision and ability to drive innovation, optimizing clinical development programs and supporting biopharma companies in navigating complex regulatory landscapes. His deep expertise in business consulting, technology, and operational management has enabled him to successfully advise executives and investors across pharmaceuticals, biotechnology, and medical devices. Currently serving as a Senior Advisor at InSilicoTrials, Michael continues to leverage his vast experience to help organizations maximize the impact of their clinical development programs and investments.

Jeffrey Miller is a seasoned expert in governance, risk management, and compliance with over two decades of experience leading corporate compliance initiatives in the healthcare and life sciences industries. Currently serving as Director-in-Charge at Granite Governance, Risk and Compliance, LLC, Jeffrey has built a reputation for integrity and strategic leadership. His career spans senior roles at notable organizations including Saxton & Stump, LLC, Asterion Consulting, and Biomet 3i, where he oversaw complex compliance programs and corporate integrity agreements. Jeffrey’s deep knowledge of healthcare law and regulatory compliance is complemented by his ability to craft innovative solutions to navigate evolving legal landscapes. In addition to his executive roles, he contributes to the field as an adjunct professor at Villanova University and through publications on compliance and cybersecurity, reinforcing his position as a thought leader in the industry.

Nina Patel Lahanis is a senior executive with over 30 years of experience in the biopharma industry, specializing in pharmacovigilance, regulatory affairs, and operational management. Currently serving as Vice President at PrimeVigilance, Nina leads strategic initiatives to ensure compliance across the Americas, optimizing resources and driving technological innovation. Throughout her career, she has excelled in business development, client relationship management, and cross-functional leadership, with a proven track record of driving revenue growth and operational efficiencies. Nina’s global experience spans multiple regions, including India, Canada, and the UK, and her multilingual skills enable her to build strong, diverse relationships. She is deeply committed to advancing regulatory safety and compliance and is eager to lend her expertise to boards and advisory roles in the biopharma and life sciences sectors.

With over 15 years of experience in technology strategy and customer success, I am passionate about leveraging digital solutions to drive transformation in the life sciences industry. From leading global teams to implementing cutting-edge technologies, my focus has always been on delivering value and driving innovation. Here is my biography.

I am excited to share my professional journey, reflecting over 27 years of experience in the pharmaceutical and biotech sectors. From co-founding Vidara Therapeutics to leading commercialization efforts at Horizon and AVM Biotechnology, my passion for innovation and growth has been at the core of my work. Here is my biography.

I'm excited to share my journey in the life sciences sector! With over 39 years of experience leading risk management strategies for FDA-regulated companies, I’ve had the opportunity to help businesses navigate complex risks and regulatory challenges across industries like medical devices, biotech, pharmaceuticals, and clinical trials. At Hylant, I lead a team dedicated to building tailored risk management frameworks that allow our clients to focus on innovation while we manage the evolving market complexities. Integrity, perseverance, and paying it forward are values that have guided me throughout my career, and I’m passionate about supporting businesses as they grow and succeed in a distracted world. Let’s connect and explore how we can collaborate to protect and grow your business!